Literature DB >> 2399259

Propionate inhibits hepatocyte lipid synthesis.

R S Wright1, J W Anderson, S R Bridges.   

Abstract

Oat bran lowers serum cholesterol in animals and humans. Propionate, a short-chain fatty acid produced by colonic bacterial fermentation of soluble fiber, is a potential mediator of this action. We tested the effect of propionate on hepatocyte lipid synthesis in rats using [1-14C]acetate, 3H2O, and [2-14C]mevalonate as precursors. Propionate produced a statistically significant inhibition of cholesterol biosynthesis from [1-14C]acetate at a concentration of 1.0 mM and from 3H2O and [2-14C]mevalonate at concentrations of 2.5 mM. Propionate also produced a significant inhibition of fatty acid biosynthesis at concentrations of 2.5 mM using [1-14C]acetate as a precursor. The demonstration of propionate-mediated inhibition of cholesterol and fatty acid biosynthesis at these concentrations suggests that propionate may inhibit cholesterol and fatty acid biosynthesis in vivo and may mediate in part the hypolipidemic effects of soluble dietary fiber. Further studies are needed to clarify this action of propionate and to establish the exact mechanisms by which the inhibition occurs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2399259     DOI: 10.3181/00379727-195-43113

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  34 in total

Review 1.  Oat: unique among the cereals.

Authors:  Masood Sadiq Butt; Muhammad Tahir-Nadeem; Muhammad Kashif Iqbal Khan; Rabia Shabir; Mehmood S Butt
Journal:  Eur J Nutr       Date:  2008-02-26       Impact factor: 5.614

Review 2.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

3.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

Review 4.  Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance.

Authors:  Paresh Dandona; Husam Ghanim; Ajay Chaudhuri; Sandeep Dhindsa; Sung Soo Kim
Journal:  Exp Mol Med       Date:  2010-04-30       Impact factor: 8.718

5.  Legume Consumption and Cardiometabolic Health.

Authors:  Nerea Becerra-Tomás; Christopher Papandreou; Jordi Salas-Salvadó
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

6.  Entire potato consumption improves lipid metabolism and antioxidant status in cholesterol-fed rat.

Authors:  Laëtitia Robert; Agnès Narcy; Edmond Rock; Christian Demigne; Andrzej Mazur; Christian Rémésy
Journal:  Eur J Nutr       Date:  2006-04-03       Impact factor: 5.614

7.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

Review 8.  The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease.

Authors:  Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

9.  Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.

Authors:  A Kaptein; L Roodenburg; H M Princen
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

10.  Resistant starch is more effective than cholestyramine as a lipid-lowering agent in the rat.

Authors:  H Younes; M A Levrat; C Demigné; C Rémésy
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.